Roche s.r.o., Praha, ČR.
Imunostimulans, interferon alfa-2a.
Trichocelulární leukemie. Kaposiho sarkom u pacientů s AIDS. Chronické myeloidní leukemie. Kožní T-buněčný lymfom. Chronická hepatitida B a C. Folikulární nehodgkinské lymfomy. Pokročilý karcinom ledviny. Maligní melanom.
Výčet balení
| 0016554 | INJ SOL 1X0.5ML/9MU S | Rp. | |
| 0016555 | INJ SOL 5X0.5ML/9MU S | Rp. | 6 539.80 |
| 0016556 | INJ SOL 1X0.5ML/6MU S | Rp. | |
| 0016557 | INJ SOL 5X0.5ML/6MU S | Rp. | 4 359.86 |
| 0016558 | INJ SOL 5X0.5ML/3MU S | Rp. | 2 179.93 |
| 0200076 | INJ SOL 1X0.5ML/3MU S | Rp. | |
| 0200077 | INJ SOL 6X0.5ML/3MU S | Rp. | |
| 0200078 | INJ SOL 12X0.5ML/3MU S | Rp. | |
| 0200079 | INJ SOL 30X0.5ML/3MU S | Rp. | |
| 0200080 | INJ SOL 6X0.5ML/6MU S | Rp. | |
| 0200081 | INJ SOL 12X0.5ML/6MU S | Rp. | |
| 0200082 | INJ SOL 30X0.5ML/6MU S | Rp. | |
| 0200083 | INJ SOL 6X0.5ML/9MU S | Rp. | |
| 0200084 | INJ SOL 12X0.5ML/9MU S | Rp. | |
| 0200085 | INJ SOL 30X0.5ML/9MU S | Rp. |